News
Establishing a Basis for Secondary Use Standards for Clinical Trials
Arpana2023-03-15T22:49:35-04:00March 8, 2023|
Applied Clinical Trials Online has published CRDSA’s paper “Establishing a basis for secondary use standards for clinical trials.” The paper reports on CRDSA’s 2022 survey of biopharma and academic researchers, and discusses how common standards can accelerate the reuse of trial data, benefiting both data contributors and the research community. CRDSA recognizes the incredible contribution of the authoring team including: Ernest Odame (Takeda), Tracy Burgess (Roche), Luk Arbuckle and Andrei Belcin Privacy Analytics), Peter Mesenbrink (Novartis); and Ramona Walls (C-Path)
Regulatory Focus Interview on CRDSA’s Supplemental Controls Demonstration Project
Arpana2023-03-16T16:42:11-04:00February 15, 2023|
Regulatory Focus, a publication of Regulatory Affairs Professional Society (RAPS), interviews CRDSA CEO Aaron Mann and COTA Healthcare’s Chief Medical Officer C.K. Wang, MD, on CRDSA’s demonstration project that seeks to establish best practices around the use of clinical trial and real-world data (RWD) in building supplemental control arms.
Webinar Recording Now Available: “Mind the Data Sharing Gap: Navigating Sponsor Policies and Data Protection Methodologies”
Arpana2022-11-10T18:54:48-05:00October 11, 2022|
The recording of the webinar, “A Review of BioPharma Sponsor Data Sharing Policies and Protection Methodologies” is now available. The webinar featured the authors from CRDSA’s white paper, exploring the papers findings, which examine sponsors’ data sharing policies and protection methodologies as well as reflections on actionable steps for sponsors and secondary analysis researchers alike.
Podcast: Unlocking the True Potential of Clinical Research Data
Arpana2022-09-26T13:38:45-04:00September 26, 2022|
In Teckro’s podcast episode “Unlocking the True Potential of Clinical Research Data,” Aaron Mann discusses the importance of unleashing the power of clinical research data. Aaron explains why he’s optimistic about the potential of data sharing among sponsors to revolutionize trial design and improve patient recruitment – and why he believes patients really want their data to be shared.
CRDSA’s Data Protection Work Group whitepaper “A Review of BioPharma Sponsor Data Sharing Policies and Protection Methodologies” is now available
Arpana2022-09-14T09:58:48-04:00September 14, 2022|
CRDSA’s Data Protection Work Group whitepaper “A Review of BioPharma Sponsor Data Sharing Policies and Protection Methodologies” is now available for download. This review of 29 sponsor policies provides valuable benchmarks, actionable steps, and insights for the researchers using shared clinical trial data.
Click here to view more information and to download!
CRDSA at the PHUSE Data Transparency Summer Event
Arpana2022-08-25T15:50:39-04:00August 25, 2022|
The PHUSE Data Transparency Summer Event included previews from Aaron Mann on CRDSA’s Data Protection Work Group; CRDSA Board Member Rebecca Li’s presentation on Vivli’s experience with the Accelerated Sharing of COVID-19 Trial Data; CRDSA Steering Committee member Elliott Zimmerman (Real Life Sciences) on how to Future Proof Patient Privacy; and CRDSA Steering Committee member Luk Arbuckle (Privacy Analytics) co-presented on “Sharing Anonymized and Functionally Effective (“SAFE”) Data.”
Events
Bio-IT World Conference & Expo
May 16 @ 8:00 AM - May 18 @ 5:00 PM EDT
Aaron Mann and Peter Mesenbrink (Novartis) join a plenary keynote panel, followed by a conference track presentation on "Evaluating Technology Approaches Using a Stakeholder-Centric Assessment Framework."